Status:

COMPLETED

CMR in Myocardial Infarction with Nonobstructive Coronary Arteries

Lead Sponsor:

The Affiliated Hospital of Xuzhou Medical University

Conditions:

Cardiac Magnetic Resonance

Myocardial Infarction with Nonobstructive Coronary Arteries

Eligibility:

All Genders

Brief Summary

MINOCA is accompanied by a worse prognosis, which is related to the inability to clarify the etiology.CMR has been explicitly recommended by guidelines as an etiologic diagnostic tool for MINOCA. Alth...

Eligibility Criteria

Inclusion

  • Complete CMR during hospitalization;
  • CAG results suggesting coronary stenosis of less than 50%;
  • peak hsTnT above the 99th percentile.

Exclusion

  • CMR image sequences are missing or of poor quality.

Key Trial Info

Start Date :

January 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 9 2024

Estimated Enrollment :

387 Patients enrolled

Trial Details

Trial ID

NCT06502899

Start Date

January 1 2019

End Date

July 9 2024

Last Update

July 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China, 221002

CMR in Myocardial Infarction with Nonobstructive Coronary Arteries | DecenTrialz